PHA-739358
Term · Oncology and biomedicine · MLC-T-ONC-006574
A substance being studied in the treatment of chronic myelogenous leukemia. PHA-739358 may stop tumor growth by blocking certain enzymes needed for cancer cells to divide and causing them to die. It is a type of kinase inhibitor.
| Identifier | MLC-T-ONC-006574 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006574",
"term": "PHA-739358",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of chronic myelogenous leukemia. PHA-739358 may stop tumor growth by blocking certain enzymes needed for cancer cells to divide and causing them to die. It is a type of kinase inhibitor.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/pha-739358/"
}
Record 13,063 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.